You don’t have to suffer for your health. If you’re anything like most Americans, the fear of painful tests prevents you from getting the help you need. If you feel that taking tests at the doctor’s office has to be invasive, let us tell you about a great way to avoid this. One of the… Read more »
Posts Categorized: News
ITSI-Biosciences wins Small Business Exporter of the Year, and is being awarded by The Saint Francis University Small Business Center, Friday June 17th, 2011. This award recognizes the outstanding achievements of the Southern Alleghenies Region’s most successful entrepreneurs and small business advocates.
ITSI-Biosciences featured in Commercial News USA, the official export magazine of the U.S. Department of Commerce. Commercial News USA is the premiere export promotion program for promoting U.S. goods and services in more than 178 countries around the world. The catalog-style magazine reaches more than a quarter million buyers and distributors worldwide. The magazine is… Read more »
Funakoshi Co., Ltd of Tokyo a leading distributor of bioreagents in Japan has been named the ITSI-Biosciences 2010 “Distributor of the Year”. This is the second time that Funakoshi is wining this distinguished and highly competitive award. Funakoshi Co., Ltd has continued to contribute to the growth of ITSI-Biosciences products in Japan. Criteria for selecting… Read more »
Mr. Koop toured the new state-of-the-art facility to learn more about ITSI’s business and operations in Johnstown. As Congressman Critz’s field representative Mr. Koop is helping ITSI-Biosciences establish strategic relationships, expand operations and take advantage of the unique opportunities for life science and biotechnology companies in the Johnstown area and 12th congressional district.
Two PhD Research Fellows from Olabisi Onabanjo University, Nigeria, arrived in Johnstown, PA today to commence research programing at ITSI – Biosciences. The two students will be in the United States for 6 months researching on Sickle Cells and Breast Cancer. Picture Legend from the left: Mutu A. Alabi (Phd Research Fellow in Breast Cancer),… Read more »
Chuck Witkowski founder of Protein Discovery visits ITSI-Biosciences facility today. Mr Witkowski is is a visionary leader with demonstrated expertise in building successful medical and life science companies from inception. Picture Legend from the left: Dr. Richard Somiari (President & Chief Scientific Officer of ITSI-Biosciences), Chuck Witkowski (President & Chief Scientific Officer)
“ITSI – Biosciences host summer interns”. Five students will be at ITSI – Biosciences for 7 weeks as interns. Three are high school graduates; Nicole Danchanko that will be going to Penn Highlands Community College in the fall to study Biology, Richard Somiari Jr going to Lehigh University also in the fall to study Computer… Read more »
ITSI, LLC today announced the commencement of the second phase of the training for the visiting Nigerian Defence Headquarters (DHQ) Knowledge Management System (KMS) project personnel in San Antonio, TX. This phase of the training is provided by BIF Technologies of San Antonio, TX. BIF is ITSI’s technical partner for implementation and management of the… Read more »
ITSIBIO today announced that ITSI Biosciences and Cybergenetics (www.cybgen.com) are collaborating to train the Nigerian Armed Forces DNA Bank (AFDB) personnel, and implement modern methods for forensic DNA analysis and interpretation in Nigeria. As part of this strategic relationship 6 AFDB personnel undergoing training at ITSI Biosciences since September 2009 have visited and trained at… Read more »
ITSIBIO has signed a representation and distribution agreement with 2B Scientific Limited, Upper Heyford, United Kingdom. 2B Scientific (www.2bscientific.com), a specialist reagents distribution company to the UK Life Science Markets will serve as a springboard for European markets. This appointment gives 2B Scientific the rights to promote, market, distribute and sell ITSIBIO products in Europe…. Read more »
ITSIBIO today announced that Nigerian Defence Headquarters Research and Development leaders, Major Gen BT Obasa (Chief, Research & Development) and Air Vice Marshall A Badeh (Director of Research) and Dr Richard I. Somiari (President & CSO) ITSI – Biosciences, LLC toured the Nigerian Armed Forces DNA Bank at Mogadishu Barracks, in Abuja, Nigeria. ITSI Biosciences… Read more »
ITSIBIO today announced that 6 Nigerian AFDB personnel visited the United States Department of Defense (DoD) Armed Forces DNA Identification Laboratory (AFDIL; www.afip.org/consultation/AFMES/AFDIL/index.html) in Rockville, MD and Armed Forces Repository of Specimen Samples for the Identification of Remains (AFRSSIR; www.afip.org/consultation/AFMES/AFDIL/AFRSSIR/) in Gaithersburg, MD. The visit is part of the comprehensive forensics DNA banking and analysis training organized… Read more »
ITSIBIO today announced that instructors from AFDIL based in Rockville, MD have arrived Johnstown, PA to help train Nigerian Armed Forces DNA Bank (AFDB) personnel. The AFDIL team led by Michael D. Coble, PhD (Research Section Chief) arrived in Johnstown, PA on the 8th of December 2009. According to Richard Somiari, PhD, President of ITSI,… Read more »
ITSI, LLC today announced the arrival of 6 Nigerian Defence Headquarters (DHQ) personnel in Johnstown, PA to commence five months computer science and knowledge management system training. According to Richard I Somiari, President and CEO of ITSI,Â the training is part of the MOU between DHQ and ITSI concerned with the design, construction and setting… Read more »
Mr. Cosgrove will be directly responsible for all aspects of business development and marketing to help ITSI Biosciences expand its domestic and international market share in academic, corporate and government sectors, as well as managing operations of the company’s business units. According to Richard Somiari, PhD, President and CEO, “We are extremely pleased to have… Read more »
Six members of the Nigerian Armed Forces DNA Bank (AFDB) representing the Army, Navy and Air force, arrived in Johnstown, PA today to commence DNA banking and analysis training at ITSI Biosciences. The team will be in the United States for 8 months learning new DNA banking and analysis methods. According to Richard Somiari, PhD,… Read more »
ITSIBIO today announced its movement into its new and larger facility. The new state-of-the-art facility in the Kernville district of Johnstown, PA is a green building with a silver status. The new facility includes more office space, expanded research laboratory and kit manufacturing space, and an ISO Certified Class 1000 clean room. This move is… Read more »
ITSIBIO today announced the introduction of a new and improved packaging for its distinctive line of ITSIPrep products. The new colorful and distinctive packaging is a marketing tool that reflects the key attributes of ITSIPrep line of products. This new packaging replaces the plain white package that the company has been using for three years…. Read more »
ITSI Bioscience has announced that it is a Subrecipient of a $2 million 5 year RO1 grant awarded to Dr Karam El-Bayoumy of Penn State University Cancer Center. This NCI subaward will fund proteomics research at ITSI Biosciences, focusing on the identification of biomarkers of prostate cancer risk. Specifically, ITSIBio will utilize high performance 2D-DIGE… Read more »
Dr. Richard Somiari, the founder of ITSI Biosciences, a life-science enterprise in the Johnstown region, is preparing to move his company into its new headquarters by year’s end–just in time to expand field investigations of a blood-sampling method that promises to increase the speed and lower the cost for early detection of breast cancer. That… Read more »
ITSIBIO has signed a representation and distribution agreement with Life Sciences-Ltda (http://www.life-sciences.com.br), Sao Paulo, Brazil. This agreement, which is effective from March 14th 2008, gives Life Sciences exclusive rights to promote, market and distribute ITSIBIO products in Brazil. Clients in this territory can now place orders for all products through Life Sciences.
ITSIBIO has signed a representation and distribution agreement with Precision Technologies PTE Ltd, Singapore (www.pretech.com.sg). This agreement, which is effective March 17th 2008, gives Precision Technologies exclusive rights to promote, market and distribute ITSIBIO products in Singapore, Malaysia and Indonesia. Clients in this territory can now place orders for all ITSIBIO products through Precision Technologies…. Read more »
The new ITSIBio facility is to be completed in August 2008.
NCI has extended the Blanket Purchase Agreement (BPA), originally signed with ITSIBIO in 2005, until 2010. This highly successful BPA which is managed by SAIC-Frederick, allows all NCI researchers to purchase genomics, proteomics and mass spectrometry services, and consumables from ITSIBIO at a pre-negotiated price. The BPA streamlines the process of outsourcing analytical support and… Read more »
ITSIBIO enters the Indian market by signing an exclusive agreement with SR Biosytem of New Delhi. Under the agreement signed May 2007, SR Biosytem will promote, market and distribute all ITSIBIO’s line of products, accessories and services in India. All orders in the Indian sub-continent should now be placed through SR Biosystem.
ITSI signs an exclusive agreement with Separation Scientific (SA) (PTY) Ltd, of South Africa. Under the agreement that is effective from April 2007, Separation Scientific will promote, market and distribute all ITSIBIO’s products and services in the South Africa and other neighboring countries. Clients in Southern Africa should now place orders through Separation Scientific (SA) (PTY).
Pennsylvania Governor Rendell announces the investment of $500,000 to enable ITSI to expand its research facility and operations.
ITSI representative invited to speak at the South African Bio2Biz International Biotechnology Conference, Durban, South Africa. A paper titled From Genomics and Proteomics to Bio-Business presented.
ITSI representative invited to speak at the International Symposium on Inflammation: An Underlying Factor in Several Diseases, Ibadan, Nigeria. A paper titled Role of Proteomics in Inflammation Research presented as a keynote lecture.
ITSI signs a collaboration agreement with the Advancement Center, College of Medicine, University of Nigeria. Under this agreement ITSI will work with the College of Medicine to develop integrated biomedical research programs and a biorepository to support cancer and complex disease research.
ITSI signs an exclusive Representative and Distributorship agreement with InterSciences Inc., Markham Ontario, Canada. Under this agreement, InterSciences will promote, market and distribute the ITSIPREP™ line of products and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay in Canada.
Dr Munir O. Azeez (Col.) of the Nigerian Army Medical Corps (NAMC) joins ITSI for six months advanced biomedical research training, as part of the training and collaboration agreement between ITSI and NAMC. Dr Azeez is interested in applying advanced proteomic technologies to study tissue from patients diagnosed with temporo-mandibular joint disease.
ITSI signs an exclusive distribution agreement with Funakoshi Japan. Funakoshi will promote, market and sell the ITSIPREP™ line of products in Japan. www.funakoshi.co.jp
ITSI signs a non-exclusive Sales Representative Agreement with Grace Scientific LLC, Clarksburg, MD, USA. Grace Scientific will promote, market and sell ITSI’s services, especially 2D-DIGE and 2D-Image analysis services and all the ITSIPREP™ line of products in the Maryland, Washington DC and Virginia area.
ITSI signs an exclusive Representative and Distributorship agreement with Rainbow Biotechnology Co., Taipei, Taiwan. Rainbow will promote, market and distribute the ITSIPREP™ line of products including optimized and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay. www.rainbowbiotech.com.tw
Itsi-Biosciences has moved to a new, larger location. Images of our new facility and additional information will available online shortly. Please see the Contact page for our new address.
ITSI appoints Syngenic Biotecnologia Ltda., Sao Paolo Brazil as the exclusive distributor of the ITSIPREP™ line of products in Brazil. The agreement, which was signed in October 2005, covers all the optimized and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay.
ITSI-Biosciences President and CSO Richard Somiari Ph.D. is prominently featured in the 11/24/05 issue of Nature.
Itsibio represented at GE Healthcare 2D-DIGE Users Group meeting in Nashville, TN. Presents paper “Application of 2D-DIGE technology for the analysis of clinical specimens.”
Robin L. Fisher, Director Asia & Europe, International Business Development, PA DCED, Mr. Donald M. Bonk, International Trade Manager, SAPDC and Ms. Sushama A Kanetkar, Director, PA Trade Representative Office in India, and Supriya, Trade & Investment Advisor, PA Trade Office India visit Itsibio corporate headquarters/laboratory to discuss export opportunities and entry into the Indian market.
ITSIBIO invited to exhibit products at the Cambria County Chamber of Commerce Small Business Expo in Ebensburg, PA
Itsibio and Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil sign agreement to explore business opportunities of mutual interest involving proteomics, clinical research/trials, tissue repository development and management. ITSIBIO representative met with Prof. Carlos Menke and staff of Hospital de Clinicas de Porto Alegre in Porto Alegre, Brazil on the… Read more »
Itsibio, Applied Isotope Technologies and MountainTop Technologies sign agreement to explore business opportunities of mutual interest involving proteomics.
Itsibio and Lampire Biological Laboratories, Pipersville, PA sign a three year collaboration and teaming agreement covering antibody production, bioreagent development and proteomics.
Itsibio signs a distribution agreement with Biomedical Marketing Associates. BMA will market and distribute ITSI’s proteomics products including protein isolation, fractionation and assay kits in 5 states: Michigan, Ohio, Kentucky, West Virginia and Western Pennsylvania.
David H. Fyock, Chairman/CEO, MountainTop Technologies Inc., Matt Pamuku, President, Applied Isotope Technologies, Inc., Prof. HM (Skip) Kingston, PhD, Duquesne University and Dr. Steve Ayanruoh, MD, Chairman, Ruskat Medical Equipment Corp and Applied Medical Technologies, visit Itsibio to discuss collaboration and teaming agreement.
Stephen C. Metzger, Director Business Lending Services of Southern Allegheny Planning & Development Commission, Altoona, PA visits itsibio to discuss funding opportunities and support. SAPDC is supporting itsibio’s effort to export bioanalytical reagents produced in Johnstown, PA to Mexico and Brazil, and to access funds through the Small Business First loan program.
D. Brian Krier (Director Business Development) and Sherry A. Davidson (Account Manager) both of The Ben Franklin Transformation Services Network, Altoona/University Park, PA visit Itsibio. Ben Franklin Technology Partners has been helping Itsibio since June of 2005 to strategize and transform our overall operations to become more efficient and competitive, both nationally and globally.
Ed Huttenhower, Director, Small Business Development Center (SBDC)/Center for Global Competitiveness, St Francis University, Loretto, PA visits Itsibio. SBDC is helping Itsibio enter foreign markets, prepare targeted marketing materials and screen foreign companies interested in distribution of Itsibio’s protein isolation and protein assay kits in Mexico and Brazil.
Prof. Francis A.A. Adeniyi, Dean, Faculty of Basic Medical Sciences and Ag. Director, Institute for Advanced Medical Research & Training (IMRAT), University of Ibadan, Ibadan, Nigeria visits itsi-Biosciences to discuss collaboration in the areas of biomedical research, bioanalytical support, tissue banking and data center development.
Itsibio acquires ProteinChip System Series 4000 Enterprise Edition Surface Enhanced Laser Desorbed Ionization – Time of Flight (SELDI-Tof) fromCiphergen Biosystems as part of an emerging collaboration between Itsibio and Ciphergen. The system, which is the best for analysis of serum, plasma, urine and saliva will support internal biomarker discovery programs and will enable Itsibio to provide contract biomarker… Read more »
Itsibio representatives visit NCI-Frederick, Frederick MD. Present seminar “Integrating emerging high throughput technologies for complex disease research”